Structure

Physi-Chem Properties

Molecular Weight:  300.1
Volume:  296.495
LogP:  2.466
LogD:  2.4
LogS:  -3.485
# Rotatable Bonds:  1
TPSA:  79.15
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.75
Synthetic Accessibility Score:  3.572
Fsp3:  0.294
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.215
MDCK Permeability:  9.091236279346049e-06
Pgp-inhibitor:  0.023
Pgp-substrate:  0.988
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.641
30% Bioavailability (F30%):  0.676

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.043
Plasma Protein Binding (PPB):  94.97911834716797%
Volume Distribution (VD):  1.284
Pgp-substrate:  5.601900100708008%

ADMET: Metabolism

CYP1A2-inhibitor:  0.844
CYP1A2-substrate:  0.863
CYP2C19-inhibitor:  0.236
CYP2C19-substrate:  0.46
CYP2C9-inhibitor:  0.414
CYP2C9-substrate:  0.912
CYP2D6-inhibitor:  0.362
CYP2D6-substrate:  0.861
CYP3A4-inhibitor:  0.828
CYP3A4-substrate:  0.522

ADMET: Excretion

Clearance (CL):  14.72
Half-life (T1/2):  0.63

ADMET: Toxicity

hERG Blockers:  0.042
Human Hepatotoxicity (H-HT):  0.13
Drug-inuced Liver Injury (DILI):  0.145
AMES Toxicity:  0.233
Rat Oral Acute Toxicity:  0.187
Maximum Recommended Daily Dose:  0.952
Skin Sensitization:  0.135
Carcinogencity:  0.094
Eye Corrosion:  0.003
Eye Irritation:  0.264
Respiratory Toxicity:  0.623

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC87794

Natural Product ID:  NPC87794
Common Name*:   3'-O-Methylbrazilin
IUPAC Name:   (6aS,11bR)-9-methoxy-7,11b-dihydro-6H-indeno[2,1-c]chromene-3,6a,10-triol
Synonyms:   3'-O-Methylbrazilin
Standard InCHIKey:  RDWWRPSMRUBPHK-DLBZAZTESA-N
Standard InCHI:  InChI=1S/C17H16O5/c1-21-15-4-9-7-17(20)8-22-14-5-10(18)2-3-11(14)16(17)12(9)6-13(15)19/h2-6,16,18-20H,7-8H2,1H3/t16-,17+/m0/s1
SMILES:  COc1cc2C[C@]3(COc4cc(ccc4[C@H]3c2cc1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2207721
PubChem CID:   13846641
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. heartwood n.a. PMID[19420770]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. heartwood n.a. PMID[21800859]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21800859]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[23127886]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[23234407]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota seeds Nanning, Guangxi Province, China 2013-APR PMID[26398312]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 50000.0 nM PMID[527340]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC87794 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC211758
0.9855 High Similarity NPC44530
0.9855 High Similarity NPC317237
0.9855 High Similarity NPC277951
0.9783 High Similarity NPC274721
0.9783 High Similarity NPC155392
0.9783 High Similarity NPC135767
0.942 High Similarity NPC94994
0.9348 High Similarity NPC162659
0.9348 High Similarity NPC265433
0.9348 High Similarity NPC248727
0.9348 High Similarity NPC270456
0.9286 High Similarity NPC184797
0.9286 High Similarity NPC309124
0.9214 High Similarity NPC245207
0.9214 High Similarity NPC236306
0.9214 High Similarity NPC260741
0.9214 High Similarity NPC473739
0.9214 High Similarity NPC70682
0.9214 High Similarity NPC127218
0.9214 High Similarity NPC25966
0.9214 High Similarity NPC232164
0.9214 High Similarity NPC319647
0.9209 High Similarity NPC234952
0.9209 High Similarity NPC230734
0.9209 High Similarity NPC227503
0.9209 High Similarity NPC474639
0.9203 High Similarity NPC317380
0.9161 High Similarity NPC473108
0.9155 High Similarity NPC107161
0.9155 High Similarity NPC59841
0.9155 High Similarity NPC2613
0.9155 High Similarity NPC204347
0.9155 High Similarity NPC475891
0.9143 High Similarity NPC276490
0.9137 High Similarity NPC112939
0.9137 High Similarity NPC474206
0.9137 High Similarity NPC470356
0.9137 High Similarity NPC94750
0.9137 High Similarity NPC121812
0.9137 High Similarity NPC151224
0.9137 High Similarity NPC112246
0.9085 High Similarity NPC247291
0.9085 High Similarity NPC471389
0.9085 High Similarity NPC35216
0.9078 High Similarity NPC32630
0.9071 High Similarity NPC173660
0.9071 High Similarity NPC306441
0.9071 High Similarity NPC16435
0.9071 High Similarity NPC302701
0.9071 High Similarity NPC269091
0.9058 High Similarity NPC127624
0.9058 High Similarity NPC86655
0.9058 High Similarity NPC202762
0.9034 High Similarity NPC233980
0.9028 High Similarity NPC469795
0.9028 High Similarity NPC280092
0.9028 High Similarity NPC45257
0.9028 High Similarity NPC12641
0.9028 High Similarity NPC50250
0.9028 High Similarity NPC93323
0.9014 High Similarity NPC160283
0.9014 High Similarity NPC259519
0.9014 High Similarity NPC254759
0.9014 High Similarity NPC27495
0.9007 High Similarity NPC474282
0.9007 High Similarity NPC103976
0.9007 High Similarity NPC102904
0.9007 High Similarity NPC176051
0.9007 High Similarity NPC211549
0.9007 High Similarity NPC107551
0.9007 High Similarity NPC326797
0.9 High Similarity NPC234333
0.9 High Similarity NPC195022
0.9 High Similarity NPC61946
0.9 High Similarity NPC47398
0.9 High Similarity NPC260898
0.9 High Similarity NPC164787
0.8993 High Similarity NPC229442
0.8993 High Similarity NPC168059
0.8993 High Similarity NPC11060
0.8973 High Similarity NPC21776
0.8973 High Similarity NPC474397
0.8973 High Similarity NPC16269
0.8958 High Similarity NPC102044
0.8958 High Similarity NPC81638
0.8958 High Similarity NPC47633
0.8958 High Similarity NPC85264
0.8951 High Similarity NPC265075
0.8951 High Similarity NPC263261
0.8951 High Similarity NPC87725
0.8944 High Similarity NPC471388
0.8944 High Similarity NPC292882
0.8944 High Similarity NPC184613
0.8929 High Similarity NPC478085
0.8926 High Similarity NPC160196
0.8913 High Similarity NPC126836
0.8912 High Similarity NPC473876
0.8897 High Similarity NPC63879
0.8889 High Similarity NPC277784
0.8881 High Similarity NPC198038
0.8865 High Similarity NPC240279
0.8865 High Similarity NPC214853
0.8865 High Similarity NPC55239
0.8865 High Similarity NPC180602
0.8865 High Similarity NPC313081
0.8865 High Similarity NPC473413
0.8857 High Similarity NPC475840
0.8857 High Similarity NPC263064
0.8857 High Similarity NPC158331
0.8849 High Similarity NPC469907
0.8844 High Similarity NPC101376
0.8836 High Similarity NPC307466
0.8836 High Similarity NPC469557
0.8828 High Similarity NPC474104
0.8828 High Similarity NPC477616
0.8828 High Similarity NPC469630
0.8828 High Similarity NPC173203
0.8828 High Similarity NPC163508
0.8819 High Similarity NPC178054
0.8819 High Similarity NPC71046
0.8819 High Similarity NPC311530
0.8811 High Similarity NPC114171
0.8811 High Similarity NPC6300
0.8811 High Similarity NPC471183
0.8811 High Similarity NPC230124
0.8808 High Similarity NPC188578
0.8808 High Similarity NPC80918
0.8803 High Similarity NPC143139
0.8803 High Similarity NPC472336
0.8803 High Similarity NPC470802
0.8803 High Similarity NPC472334
0.8803 High Similarity NPC133025
0.8803 High Similarity NPC202846
0.8794 High Similarity NPC209199
0.8794 High Similarity NPC188378
0.8794 High Similarity NPC206737
0.8794 High Similarity NPC106215
0.8794 High Similarity NPC276026
0.8794 High Similarity NPC555
0.8794 High Similarity NPC170694
0.8794 High Similarity NPC287745
0.8794 High Similarity NPC7515
0.8794 High Similarity NPC56764
0.8794 High Similarity NPC469659
0.8794 High Similarity NPC289258
0.8786 High Similarity NPC253105
0.8786 High Similarity NPC204215
0.8786 High Similarity NPC61477
0.8786 High Similarity NPC78770
0.8786 High Similarity NPC126029
0.8786 High Similarity NPC219876
0.8786 High Similarity NPC261619
0.8786 High Similarity NPC185604
0.8786 High Similarity NPC201587
0.8786 High Similarity NPC15658
0.8786 High Similarity NPC175067
0.8786 High Similarity NPC6451
0.8784 High Similarity NPC329836
0.8777 High Similarity NPC91291
0.8776 High Similarity NPC324492
0.8776 High Similarity NPC317053
0.8776 High Similarity NPC260397
0.8776 High Similarity NPC112251
0.8768 High Similarity NPC226331
0.8768 High Similarity NPC46274
0.8767 High Similarity NPC304894
0.8767 High Similarity NPC473845
0.8767 High Similarity NPC15659
0.8759 High Similarity NPC470917
0.875 High Similarity NPC109240
0.875 High Similarity NPC22317
0.875 High Similarity NPC266197
0.875 High Similarity NPC234568
0.875 High Similarity NPC291101
0.8741 High Similarity NPC301765
0.8741 High Similarity NPC156948
0.8741 High Similarity NPC477938
0.8741 High Similarity NPC35550
0.8741 High Similarity NPC86605
0.8741 High Similarity NPC3072
0.8741 High Similarity NPC46277
0.8733 High Similarity NPC2745
0.8732 High Similarity NPC10314
0.8732 High Similarity NPC472337
0.8732 High Similarity NPC108198
0.8732 High Similarity NPC126409
0.8732 High Similarity NPC134968
0.8732 High Similarity NPC99572
0.8732 High Similarity NPC200557
0.8732 High Similarity NPC158142
0.8732 High Similarity NPC69029
0.8732 High Similarity NPC294884
0.8725 High Similarity NPC476969
0.8723 High Similarity NPC36661
0.8723 High Similarity NPC32778
0.8716 High Similarity NPC327412
0.8716 High Similarity NPC320970
0.8716 High Similarity NPC328567
0.8716 High Similarity NPC320671

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC87794 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8786 High Similarity NPD1612 Clinical (unspecified phase)
0.8786 High Similarity NPD1613 Approved
0.8768 High Similarity NPD1529 Clinical (unspecified phase)
0.8696 High Similarity NPD1530 Clinical (unspecified phase)
0.8571 High Similarity NPD3027 Phase 3
0.8369 Intermediate Similarity NPD4908 Phase 1
0.8298 Intermediate Similarity NPD2861 Phase 2
0.8261 Intermediate Similarity NPD1610 Phase 2
0.8252 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD4625 Phase 3
0.8138 Intermediate Similarity NPD3620 Phase 2
0.8138 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD7199 Phase 2
0.8025 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1934 Approved
0.8014 Intermediate Similarity NPD4749 Approved
0.7888 Intermediate Similarity NPD6234 Discontinued
0.7877 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7842 Intermediate Similarity NPD1548 Phase 1
0.7815 Intermediate Similarity NPD5762 Approved
0.7815 Intermediate Similarity NPD5763 Approved
0.7778 Intermediate Similarity NPD3892 Phase 2
0.777 Intermediate Similarity NPD4060 Phase 1
0.775 Intermediate Similarity NPD2801 Approved
0.7718 Intermediate Similarity NPD5735 Approved
0.7712 Intermediate Similarity NPD6674 Discontinued
0.7712 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD37 Approved
0.7671 Intermediate Similarity NPD3018 Phase 2
0.7665 Intermediate Similarity NPD7228 Approved
0.7658 Intermediate Similarity NPD1653 Approved
0.7654 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD4965 Approved
0.7654 Intermediate Similarity NPD3882 Suspended
0.7654 Intermediate Similarity NPD4966 Approved
0.7654 Intermediate Similarity NPD4967 Phase 2
0.7651 Intermediate Similarity NPD6166 Phase 2
0.7651 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD5283 Phase 1
0.755 Intermediate Similarity NPD6353 Approved
0.7531 Intermediate Similarity NPD1465 Phase 2
0.7517 Intermediate Similarity NPD2983 Phase 2
0.7517 Intermediate Similarity NPD5327 Phase 3
0.7517 Intermediate Similarity NPD2982 Phase 2
0.7516 Intermediate Similarity NPD6099 Approved
0.7516 Intermediate Similarity NPD1511 Approved
0.7516 Intermediate Similarity NPD6100 Approved
0.7515 Intermediate Similarity NPD5844 Phase 1
0.75 Intermediate Similarity NPD3705 Approved
0.7483 Intermediate Similarity NPD4624 Approved
0.7471 Intermediate Similarity NPD7074 Phase 3
0.7468 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD228 Approved
0.7456 Intermediate Similarity NPD3818 Discontinued
0.7448 Intermediate Similarity NPD2981 Phase 2
0.7421 Intermediate Similarity NPD1512 Approved
0.7417 Intermediate Similarity NPD4140 Approved
0.7415 Intermediate Similarity NPD3094 Phase 2
0.7412 Intermediate Similarity NPD7054 Approved
0.741 Intermediate Similarity NPD5494 Approved
0.7397 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD3817 Phase 2
0.7376 Intermediate Similarity NPD6671 Approved
0.7368 Intermediate Similarity NPD7472 Approved
0.7368 Intermediate Similarity NPD3657 Discovery
0.7365 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD8054 Approved
0.7356 Intermediate Similarity NPD8053 Approved
0.7341 Intermediate Similarity NPD7549 Discontinued
0.7321 Intermediate Similarity NPD6232 Discontinued
0.7319 Intermediate Similarity NPD3022 Approved
0.7319 Intermediate Similarity NPD3021 Approved
0.7314 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD1558 Phase 1
0.7299 Intermediate Similarity NPD4578 Approved
0.7299 Intermediate Similarity NPD7311 Approved
0.7299 Intermediate Similarity NPD4577 Approved
0.7299 Intermediate Similarity NPD7312 Approved
0.7299 Intermediate Similarity NPD7313 Approved
0.7299 Intermediate Similarity NPD7310 Approved
0.7294 Intermediate Similarity NPD7473 Discontinued
0.7285 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD4005 Discontinued
0.7283 Intermediate Similarity NPD7685 Pre-registration
0.7279 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4663 Approved
0.726 Intermediate Similarity NPD1091 Approved
0.726 Intermediate Similarity NPD3092 Approved
0.7257 Intermediate Similarity NPD7309 Approved
0.7255 Intermediate Similarity NPD6355 Discontinued
0.7255 Intermediate Similarity NPD5124 Phase 1
0.7255 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD7447 Phase 1
0.7239 Intermediate Similarity NPD4678 Approved
0.7239 Intermediate Similarity NPD4675 Approved
0.7235 Intermediate Similarity NPD2489 Approved
0.7235 Intermediate Similarity NPD27 Approved
0.7232 Intermediate Similarity NPD7906 Approved
0.723 Intermediate Similarity NPD6696 Suspended
0.723 Intermediate Similarity NPD8651 Approved
0.7226 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6797 Phase 2
0.7215 Intermediate Similarity NPD7466 Approved
0.7215 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6331 Phase 2
0.7215 Intermediate Similarity NPD3750 Approved
0.7212 Intermediate Similarity NPD7819 Suspended
0.7208 Intermediate Similarity NPD6653 Approved
0.7188 Intermediate Similarity NPD7213 Phase 3
0.7188 Intermediate Similarity NPD7212 Phase 2
0.7186 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7831 Phase 2
0.7186 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7833 Phase 2
0.7184 Intermediate Similarity NPD7251 Discontinued
0.7184 Intermediate Similarity NPD7240 Approved
0.7176 Intermediate Similarity NPD2969 Approved
0.7176 Intermediate Similarity NPD2970 Approved
0.717 Intermediate Similarity NPD2677 Approved
0.7161 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD4538 Approved
0.7161 Intermediate Similarity NPD4536 Approved
0.716 Intermediate Similarity NPD8127 Discontinued
0.7152 Intermediate Similarity NPD5177 Phase 3
0.7152 Intermediate Similarity NPD1652 Phase 2
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7808 Phase 3
0.7143 Intermediate Similarity NPD422 Phase 1
0.7143 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1375 Discontinued
0.7134 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3540 Phase 1
0.7134 Intermediate Similarity NPD7266 Discontinued
0.7134 Intermediate Similarity NPD4380 Phase 2
0.7133 Intermediate Similarity NPD7157 Approved
0.7126 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD5058 Phase 3
0.7122 Intermediate Similarity NPD2684 Approved
0.7118 Intermediate Similarity NPD7229 Phase 3
0.7118 Intermediate Similarity NPD3051 Approved
0.7118 Intermediate Similarity NPD3787 Discontinued
0.7115 Intermediate Similarity NPD5588 Approved
0.7108 Intermediate Similarity NPD5929 Approved
0.7107 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD4110 Phase 3
0.7105 Intermediate Similarity NPD7095 Approved
0.7103 Intermediate Similarity NPD3091 Approved
0.7099 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD2157 Approved
0.7089 Intermediate Similarity NPD1549 Phase 2
0.7083 Intermediate Similarity NPD7075 Discontinued
0.7083 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD2238 Phase 2
0.7073 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD3539 Phase 1
0.7066 Intermediate Similarity NPD2563 Approved
0.7066 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD2560 Approved
0.7062 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6959 Discontinued
0.7042 Intermediate Similarity NPD7843 Approved
0.7037 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7028 Phase 2
0.7025 Intermediate Similarity NPD6005 Phase 3
0.7025 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6004 Phase 3
0.7025 Intermediate Similarity NPD6002 Phase 3
0.702 Intermediate Similarity NPD6584 Phase 3
0.7019 Intermediate Similarity NPD7124 Phase 2
0.7018 Intermediate Similarity NPD6071 Discontinued
0.7011 Intermediate Similarity NPD8156 Discontinued
0.7007 Intermediate Similarity NPD4059 Approved
0.7006 Intermediate Similarity NPD7033 Discontinued
0.7006 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5960 Phase 3
0.6989 Remote Similarity NPD6559 Discontinued
0.6988 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6987 Remote Similarity NPD4097 Suspended
0.6982 Remote Similarity NPD4055 Discovery
0.6981 Remote Similarity NPD970 Clinical (unspecified phase)
0.6981 Remote Similarity NPD2424 Discontinued
0.6975 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6975 Remote Similarity NPD4357 Discontinued
0.6966 Remote Similarity NPD7340 Approved
0.6962 Remote Similarity NPD2161 Phase 2
0.6954 Remote Similarity NPD8099 Discontinued
0.6954 Remote Similarity NPD3751 Discontinued
0.6954 Remote Similarity NPD8251 Approved
0.6954 Remote Similarity NPD8252 Approved
0.695 Remote Similarity NPD4750 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data